ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $644,000 | -22.8% | 5,000 | 0.0% | 0.17% | -38.7% |
| Q4 2020 | $834,000 | +8.0% | 5,000 | 0.0% | 0.27% | +56.6% |
| Q3 2020 | $772,000 | +4.3% | 5,000 | 0.0% | 0.18% | +4.8% |
| Q2 2020 | $740,000 | +31.4% | 5,000 | 0.0% | 0.17% | +57.5% |
| Q1 2020 | $563,000 | -71.3% | 5,000 | -64.5% | 0.11% | -28.9% |
| Q4 2019 | $1,960,000 | +1.8% | 14,090 | -29.6% | 0.15% | +24.2% |
| Q3 2019 | $1,926,000 | – | 20,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |